New combo pill aims to extend life in tough bile duct cancer
Disease control
Not yet recruiting
This study tests whether adding an experimental drug (D07001) to standard chemotherapy (capecitabine) helps people with advanced biliary tract cancer live longer. About 195 adults whose cancer has not responded to previous treatments will receive either D07001 or a placebo, plus …
Phase: PHASE3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC